Both in Pharmaceuticals
Prestige Consumer Healthcare vs Immunome
Over the past year PBH returned −23.1% and IMNM returned +11.8%; their daily moves had a correlation of 0.14.
PBH −23.1% IMNM +11.8%Growth of $1, one year, split-adjusted
| Metric | PBH | IMNM |
|---|---|---|
| Price | $47.97 | $18.57 |
| Market cap | $2.27B | $2.19B |
| Today | +1.22% | −1.09% |
| 1 month | +2.6% | −15.2% |
| 6 months | −14.4% | −19.1% |
| Year to date | −22.2% | −13.6% |
| 1 year | −23.1% | +11.8% |
| Revenue growth (YoY) | +6.5% | −100.0% |
| Gross margin | 51.3% | — |
| Net margin | 11.0% | — |
| P/E (TTM) | 13.2× | — |
| Price / sales | 2.1× | — |
| Net cash | -$1.95B | $520.0M |
| Dividend yield | — | — |
| Volatility (60d) | 31.3% | 55.7% |
| Short % of float | 8.5% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).